A5051848306- BRCA gene mutations in cancer
- Reconstructive Surgery and Microvascular Techniques
- Sarcoma Diagnosis and Treatment
- Cancer Genomics and Diagnostics
- Soft tissue tumor case studies
- Dialysis and Renal Disease Management
- Infectious Aortic and Vascular Conditions
- Venous Thromboembolism Diagnosis and Management
- Diagnosis and Treatment of Venous Diseases
- Tumors and Oncological Cases
- Central Venous Catheters and Hemodialysis
- Cardiac tumors and thrombi
- Vascular Tumors and Angiosarcomas
- Minimally Invasive Surgical Techniques
- Ovarian cancer diagnosis and treatment
- Economic and Financial Impacts of Cancer
- Systemic Sclerosis and Related Diseases
- Hernia repair and management
- Prenatal Screening and Diagnostics
- Male Breast Health Studies
- Advanced Breast Cancer Therapies
- Vascular Procedures and Complications
- Head and Neck Surgical Oncology
- Gallbladder and Bile Duct Disorders
- Surgical site infection prevention
Mayo Clinic in Arizona
2021-2025
Creative Commons
2021-2022
e13036 Background: In January 2023, the FDA approved elacestrant for ESR1-mutated, ER+/HER2- MBC based on a companion diagnostic cell free (cf)DNA test (Guardant Health). this study, we analyze trends of liquid biopsy utilization at Mayo Clinic (MC) over 3 year period to understand impact drug approval testing patterns and identify emergent alterations in patients (pts) with MBC. Methods: We extracted clinically performed Guardant 360 CDx ordered MC sites Rochester (MN), Florida (FL),...
BackgroundArteriovenous fistulas (AVFs) are indispensable in the care of patients with end-stage renal disease requiring hemodialysis. Obesity is a common comorbidity hemodialysis patients, often making AVF cannulation technically challenging. Liposuction can be performed for superficialization without need an open procedure. The aim present study was to evaluate outcomes liposuction improve access hemodialysis.MethodsWe retrospective medical record review who had undergone over at our...
Background: We aim to describe the reconstructive approach radiation-induced secondary and recurrent breast angiosarcomas at our institution. Methods: retrospectively reviewed angiosarcoma resection patients who required reconstruction from January 2000 April 2020. Results: Of thirty-nine total patients, 25 (64%) presented with fourteen (36%) angiosarcoma. Average follow up was 4.4 years. 21 (84%) underwent mastectomy 4 (16%) wide local excision. Twelve were reconstructed thoracoabdominal...
BACKGROUND: Intraoperative radiation therapy is often used as an adjuvant treatment for locally advanced tumors. Reconstruction of defects after oncological resection challenging. We present the largest cohort to date assessing safety and effectiveness flap reconstruction in these patients. METHODS: A retrospective review patients who underwent intraoperative simultaneous reasons was done. Inclusion criterion 18 years or older this procedure from January 2010 2020 at our institution....